{"id":50496,"date":"2022-11-04T13:02:25","date_gmt":"2022-11-04T12:02:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/"},"modified":"2022-11-04T13:02:25","modified_gmt":"2022-11-04T12:02:25","slug":"cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/","title":{"rendered":"Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023"},"content":{"rendered":"
\n

\nLong-awaited milestone gives physicians and their patients greater access to prescription cardiac arrhythmia detection solutions, including the company\u2019s Cardea SOLO\u2122 ECG System<\/i>\n<\/p>\n

BELLEVUE, Wash.–(BUSINESS WIRE)–#ECGscreening<\/a>—Cardiac Insight, Inc<\/a>., creators of Cardea SOLO\u2122<\/a> prescription cardiac sensors and automated electrocardiography (ECG) Analysis Software, shares its perspective on the latest CMS ruling, which provides nationwide physician confidence in receiving the appropriate reimbursement for prescribing LT-ECG (Long Term ECG) ambulatory diagnostic testing. The new Medicare Physician Fee Schedule (MPFS) rule establishes national Medicare and Medicaid payment rates for ambulatory diagnostic ECG solutions, including Cardiac Insight\u2019s Cardea SOLO ECG System.\n<\/p>\n

<\/a><\/p>\n

\nOn November 1, 2022, the Centers for Medicare and Medicaid Services (CMS) issued the CY 2023 MPFS Final Rule<\/a> (CMS-1770-F). In this Final Rule, CMS finalized payment policies and rates for External Extended ECG Monitoring under the MPFS that go into effect on January 1, 2023.\n<\/p>\n

\nThe 2023 MPFS includes payment rates for Category I CPT codes 93241-93248 that cover external ECG testing procedures with an indicated wear-time greater than 48 hours and up to 15 days. Healthcare professionals primarily rely on CPT global code 93241 when billing and seeking reimbursement for Cardiac Insight\u2019s flagship product, the Cardea SOLO ECG System. Cardea SOLO ECG consists of a single-use, chest-worn, 7-day prescription ECG wearable device used with the leading automated arrhythmia Analysis Software operating entirely at the point of clinical patient care. This reduces the need for ECG services outsourcing, relieves the often-associated patient reporting delays and provides economic practice benefits to physicians.\n<\/p>\n

\nIn the MPFS 2023 Final Rule, CMS established a national relative value unit (\u201cRVU\u201d) of 7.89 for CPT code 93241 and a Calendar Year (\u201cCY\u201d) 2023 Conversion Factor of $33.06, indicating a national payment rate of $260.84\n<\/p>\n

\n\u201cWe appreciate CMS\u2019s evaluation of the cost inputs provided and their focus on establishing national rates for the Long-Term continuous ECG monitoring category,\u201d said Min Kim, Chief Executive Officer of Cardiac Insight. \u201cThis long-awaited milestone provides more healthcare providers and their patients nationwide with greater access to our highly differentiated cardiac arrhythmia detection solutions.\u201d<\/i>\n<\/p>\n

\n\u201cOur experience is that physician use of Cardea SOLO ECG can streamline cardiac arrhythmia diagnosis, reinforce the physician-patient relationship, and help patients with serious arrhythmias, including atrial fibrillation, obtain treatment sooner,\u201d continued Mr. Kim.<\/i>\n<\/p>\n

\nAbout Cardiac Insight, Inc.<\/b>\n<\/p>\n

\nCardiac Insight, Inc.<\/a> (www.cardiacinsightinc.com<\/a>) is a leading U.S. digital healthcare innovator specializing in the development of medical-grade, body-worn sensor technology and automated cardiac analysis solutions through its proprietary algorithms and software platforms. The company\u2019s products include the Cardea SOLO\u2122 wearable ECG Sensor and Software Analysis System, and the Cardea 20\/20 ECG\u2122 \u2013 the only resting 12 Lead ECG System designed for cardiac risk screening in young athletes at all levels of play.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMichele Nachum, Firecracker PR
\n
michele@firecrackerpr.com<\/a>\n<\/p>\n

\nAnn Demaree, RN, Cardiac Insight
\n
ademaree@cardiacinsightinc.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Long-awaited milestone gives physicians and their patients greater access to prescription cardiac arrhythmia detection solutions, including the company\u2019s Cardea SOLO\u2122 ECG System BELLEVUE, Wash.–(BUSINESS WIRE)–#ECGscreening—Cardiac Insight, Inc., creators of Cardea SOLO\u2122 prescription cardiac sensors and automated electrocardiography (ECG) Analysis Software, shares its perspective on the latest CMS ruling, which provides nationwide physician confidence in receiving … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50496","6":"format-standard","7":"category-industry"},"yoast_head":"\nCardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Long-awaited milestone gives physicians and their patients greater access to prescription cardiac arrhythmia detection solutions, including the company\u2019s Cardea SOLO\u2122 ECG System BELLEVUE, Wash.–(BUSINESS WIRE)–#ECGscreening—Cardiac Insight, Inc., creators of Cardea SOLO\u2122 prescription cardiac sensors and automated electrocardiography (ECG) Analysis Software, shares its perspective on the latest CMS ruling, which provides nationwide physician confidence in receiving ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-04T12:02:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221104005115\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023\",\"datePublished\":\"2022-11-04T12:02:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/\"},\"wordCount\":475,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005115\\\/en\\\/1511708\\\/21\\\/Cardiac_Insight_logo_4c_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/\",\"name\":\"Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005115\\\/en\\\/1511708\\\/21\\\/Cardiac_Insight_logo_4c_%281%29.jpg\",\"datePublished\":\"2022-11-04T12:02:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005115\\\/en\\\/1511708\\\/21\\\/Cardiac_Insight_logo_4c_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005115\\\/en\\\/1511708\\\/21\\\/Cardiac_Insight_logo_4c_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/","og_locale":"en_US","og_type":"article","og_title":"Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023 - Pharma Trend","og_description":"Long-awaited milestone gives physicians and their patients greater access to prescription cardiac arrhythmia detection solutions, including the company\u2019s Cardea SOLO\u2122 ECG System BELLEVUE, Wash.–(BUSINESS WIRE)–#ECGscreening—Cardiac Insight, Inc., creators of Cardea SOLO\u2122 prescription cardiac sensors and automated electrocardiography (ECG) Analysis Software, shares its perspective on the latest CMS ruling, which provides nationwide physician confidence in receiving ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-04T12:02:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221104005115\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023","datePublished":"2022-11-04T12:02:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/"},"wordCount":475,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221104005115\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/","url":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/","name":"Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221104005115\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg","datePublished":"2022-11-04T12:02:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221104005115\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221104005115\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cardiac-insight-comments-on-cms-announcement-of-national-payment-rates-for-long-term-continuous-ecg-lt-ecg-monitoring-in-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50496"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50496\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50496"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50496"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}